Efficacy and Safety of Gefitinib in Patients with Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Trials on assessing the benefits of EGFR inhibitors in head and neck squamous cell carcinoma (HNSCC) patients have gradually been published. Nevertheless, the benefits of gefitinib in advanced HNSCC are still unknown. METHODS: The Cochrane library, PubMed, and EMBASE databases were syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiaoxia, He, Juan, Li, Bo, Zheng, Yi, Li, Kejia, Zou, Shun, Chen, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556337/
https://www.ncbi.nlm.nih.gov/pubmed/31239839
http://dx.doi.org/10.1155/2019/6273438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556337/
https://www.ncbi.nlm.nih.gov/pubmed/31239839
http://dx.doi.org/10.1155/2019/6273438

Ejemplares similares